Bio-Techne (TECH) Operating Leases (2019 - 2025)
Historic Operating Leases for Bio-Techne (TECH) over the last 7 years, with Q4 2025 value amounting to $77.2 million.
- Bio-Techne's Operating Leases fell 542.91% to $77.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $77.2 million, marking a year-over-year decrease of 542.91%. This contributed to the annual value of $84.0 million for FY2025, which is 417.49% down from last year.
- Per Bio-Techne's latest filing, its Operating Leases stood at $77.2 million for Q4 2025, which was down 542.91% from $80.7 million recorded in Q3 2025.
- In the past 5 years, Bio-Techne's Operating Leases ranged from a high of $97.3 million in Q3 2023 and a low of $56.3 million during Q1 2022
- Its 5-year average for Operating Leases is $78.2 million, with a median of $80.1 million in 2025.
- Its Operating Leases has fluctuated over the past 5 years, first plummeted by 1566.69% in 2022, then skyrocketed by 6551.96% in 2023.
- Bio-Techne's Operating Leases (Quarter) stood at $57.7 million in 2021, then surged by 35.46% to $78.2 million in 2022, then grew by 22.82% to $96.0 million in 2023, then fell by 15.01% to $81.6 million in 2024, then fell by 5.43% to $77.2 million in 2025.
- Its Operating Leases stands at $77.2 million for Q4 2025, versus $80.7 million for Q3 2025 and $84.0 million for Q2 2025.